{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T04:09:23Z","timestamp":1744258163068,"version":"3.40.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"HERTAPE SA\u00daDE ANIMAL","award":["Dont applied"],"award-info":[{"award-number":["Dont applied"]}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","award":["Dont applied"],"award-info":[{"award-number":["Dont applied"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s42770-020-00247-8","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T10:03:08Z","timestamp":1583488988000},"page":"1439-1445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Short communication: a modified Vaccinia virus Ankara-based Porcine circovirus 2 vaccine elicits strong antibody response upon prime-boost homologous immunization in a preclinical model"],"prefix":"10.1007","volume":"51","author":[{"given":"Danielle Soares","family":"de Oliveira Daian e Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edel Figueiredo","family":"Barbosa-Stancioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana Graziela Alves","family":"Coelho-Dos-Reis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1416-8694","authenticated-orcid":false,"given":"Fl\u00e1vio Guimar\u00e3es","family":"Da Fonseca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"Suppl 1","key":"247_CR1","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1865-1682.2012.01312.x","volume":"59","author":"PR Davies","year":"2012","unstructured":"Davies PR (2012) One world, one health: the threat of emerging swine diseases. A north American perspective. Transbound Emerg Dis 59(Suppl 1):18\u201326. https:\/\/doi.org\/10.1111\/j.1865-1682.2012.01312.x","journal-title":"Transbound Emerg Dis"},{"key":"247_CR2","doi-asserted-by":"publisher","first-page":"12813","DOI":"10.1128\/JVI.01719-09","volume":"83","author":"C Firth","year":"2009","unstructured":"Firth C, Charleston MA, Duffy S, Shapiro B, Holmes EC (2009) Insights into the evolutionary history of an emerging livestock pathogen: Porcine circovirus 2. J Virol 83:12813\u201312821. https:\/\/doi.org\/10.1128\/JVI.01719-09","journal-title":"J Virol"},{"key":"247_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.bbrc.2009.01.001","volume":"379","author":"WL Lin","year":"2009","unstructured":"Lin WL, Chien MS, Du Y, Wu PC, Huang C (2009) The N-terminus of porcine Circovirus type 2 replication protein is required for nuclear localization and ori binding activities. Biochem Biophys Res Commun 379:1066\u20131071. https:\/\/doi.org\/10.1016\/j.bbrc.2009.01.001","journal-title":"Biochem Biophys Res Commun"},{"key":"247_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1079\/AHR2005106","volume":"6","author":"J Segal\u00e9s","year":"2005","unstructured":"Segal\u00e9s J, Allan GM, Domingo M (2005) Porcine Circovirus diseases. Anim Health Res Rev 6:119\u2013142","journal-title":"Anim Health Res Rev"},{"key":"247_CR5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1146\/annurev-animal-031412-103720","volume":"1","author":"XJ Meng","year":"2013","unstructured":"Meng XJ (2013) Porcine Circovirus type 2 (PCV2): pathogenesis and interaction with the immune system. Annu Rev Anim Biosci 1:43\u201364. https:\/\/doi.org\/10.1146\/annurev-animal-031412-103720","journal-title":"Annu Rev Anim Biosci"},{"key":"247_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.vaccine.2008.11.105","volume":"27","author":"T Opriessnig","year":"2009","unstructured":"Opriessnig T, Patterson AR, Madson DM, Pal N, Halbur PG (2009) Comparison of efficacy of commercial one dose and two dose PCV2 vaccines using a mixed PRRSV\u2013PCV2\u2013SIV clinical infection model 2\u20133-months post vaccination. Vaccine 27:1002\u20131007. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.105","journal-title":"Vaccine"},{"key":"247_CR7","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00253-014-6167-8","volume":"99","author":"Y Wang","year":"2015","unstructured":"Wang Y, Lu Y, Liu D, Wei Y, Guo L, Wu H, Huang L, Liu J, Liu C (2015) Enhanced Th1-biased immune efficacy of porcine Circovirus type 2 cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice. Appl Microbiol Biotechnol 99:1155\u20131163. https:\/\/doi.org\/10.1007\/s00253-014-6167-8","journal-title":"Appl Microbiol Biotechnol"},{"key":"247_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virusres.2015.02.010","volume":"201","author":"LL Zheng","year":"2015","unstructured":"Zheng LL, Guo XQ, Zhu QL, Chao AJ, Fu PF, Wei ZY, Wang SJ, Chen HY, Cui BA (2015) Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine Circovirus type 2 capsid protein and interleukin 18. Virus Res 201:8\u201315. https:\/\/doi.org\/10.1016\/j.virusres.2015.02.010","journal-title":"Virus Res"},{"issue":"12","key":"247_CR9","doi-asserted-by":"publisher","first-page":"4839","DOI":"10.3390\/v6124839","volume":"6","author":"H Zhang","year":"2014","unstructured":"Zhang H, Qian P, Liu L, Qian S, Chen H, Li X (2014) Virus-like particles of chimeric recombinant porcine Circovirus type 2 as antigen vehicle carrying foreign epitopes. Viruses 6(12):4839\u20134855. https:\/\/doi.org\/10.3390\/v6124839","journal-title":"Viruses"},{"key":"247_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.vetmic.2006.11.027","volume":"121","author":"X Wang","year":"2007","unstructured":"Wang X, Jiang P, Li Y, Jiang W, Dong X (2007) Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine Circovirus type 2. Vet Microbiol 121:215\u2013224. https:\/\/doi.org\/10.1016\/j.vetmic.2006.11.027","journal-title":"Vet Microbiol"},{"key":"247_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jviromet.2008.02.014","volume":"150","author":"K Wang","year":"2008","unstructured":"Wang K, Huang L, Kong J, Zhang X (2008) Expression of the capsid protein of porcine Circovirus type 2 in Lactococcus lactis for oral vaccination. J Virol Methods 150:1\u20136. https:\/\/doi.org\/10.1016\/j.jviromet.2008.02.014","journal-title":"J Virol Methods"},{"key":"247_CR12","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.vaccine.2008.11.094","volume":"27","author":"C Carson","year":"2009","unstructured":"Carson C, Antoniou M, Ruiz-Arg\u00fcello MB, Alcami A, Christodoulou V, Messaritakis I, Blackwell JM, Courtenay O (2009) A prime\/boost DNA\/modified Vaccinia virus Ankara vaccine expressing recombinant Leishmania DNA encoding TRYP is safe and immunogenic in outbred dogs, the reservoir of zoonotic visceral leishmaniasis. Vaccine 27:1080\u20131086. https:\/\/doi.org\/10.1016\/j.vaccine.2008.11.094","journal-title":"Vaccine"},{"key":"247_CR13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.vaccine.2007.11.021","volume":"26","author":"I Ramos","year":"2008","unstructured":"Ramos I, Alonso A, Marcen JM, Peris A, Castillo JA, Colmenares M, Larraga V (2008) Heterologous prime-boost vaccination with a non-replicative Vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response. Vaccine 26:333\u2013344. https:\/\/doi.org\/10.1016\/j.vaccine.2007.11.021","journal-title":"Vaccine"},{"key":"247_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.micinf.2005.10.004","volume":"8","author":"E P\u00e9rez-Jim\u00e9nez","year":"2006","unstructured":"P\u00e9rez-Jim\u00e9nez E, Kochan G, Gherardi M, Esteban M (2006) MVA-LACK as a safe and efficient vector for vaccination against leishmaniasis. Microbes Infect 8:810\u2013822. https:\/\/doi.org\/10.1016\/j.micinf.2005.10.004","journal-title":"Microbes Infect"},{"key":"247_CR15","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1089\/vim.2011.0018","volume":"24","author":"MF Ferrer","year":"2011","unstructured":"Ferrer MF, Zajac MPDM, Zanetti FA, Valera AR, Zabal O, Calamante G (2011) Recombinant MVA expressing secreted glycoprotein D of BoHV-1 induces systemic and mucosal immunity in animal models. Viral Immunol 24:331\u2013339. https:\/\/doi.org\/10.1089\/vim.2011.0018","journal-title":"Viral Immunol"},{"key":"247_CR16","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.vaccine.2009.10.027","volume":"28","author":"E Calvo-Pinilla","year":"2010","unstructured":"Calvo-Pinilla E, Rodr\u00edguez-Calvo T, Sevilla N, Ortego J (2010) Heterologous prime boost vaccination with DNA and recombinant modified Vaccinia virus Ankara protects IFNAR (\u2212\/\u2212) mice against lethal bluetongue infection. Vaccine 28:437\u2013445. https:\/\/doi.org\/10.1016\/j.vaccine.2009.10.027","journal-title":"Vaccine"},{"key":"247_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0016503","volume":"6","author":"J Castillo-Olivares","year":"2011","unstructured":"Castillo-Olivares J, Calvo-Pinilla E, Casanova I, Bachanek-Bankowska K, Chiam R, Maan S, Nieto JM, Ortego J, Mertens PPC (2011) A modified Vaccinia Ankara virus (MVA) vaccine expressing African Horse Sickness Virus (AHSV) VP2 protects against AHSV challenge in an IFNAR \u2212\/\u2212 mouse model. PLoS One 6:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0016503","journal-title":"PLoS One"},{"key":"247_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0005997","volume":"4","author":"R Chiam","year":"2009","unstructured":"Chiam R, Sharp E, Maan S, Rao S, Mertens P, Blacklaws B, Davis-Poynter N, Wood J, Castillo-Olivares J (2009) Induction of antibody responses to African Horse Sickness Virus (AHSV) in ponies after vaccination with recombinant modified Vaccinia Ankara (MVA). PLoS One 4:1\u20139. https:\/\/doi.org\/10.1371\/journal.pone.0005997","journal-title":"PLoS One"},{"issue":"51","key":"247_CR19","doi-asserted-by":"publisher","first-page":"7198","DOI":"10.1016\/j.vaccine.2009.09.033","volume":"27","author":"J Weyer","year":"2009","unstructured":"Weyer J, Rupprechet CE, Nel LH (2009) Poxvirus-vectored vaccines for rabies-a review. Vaccine 27(51):7198\u20137201. https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.033","journal-title":"Vaccine"},{"key":"247_CR20","doi-asserted-by":"publisher","first-page":"6641","DOI":"10.1073\/pnas.0401939101","volume":"101","author":"H Bisht","year":"2004","unstructured":"Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B (2004) Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proc Natl Acad Sci U S A 101:6641\u20136646. https:\/\/doi.org\/10.1073\/pnas.0401939101","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"247_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1007\/s42770-019-00067-5","volume":"50","author":"DSO Daian e Silva","year":"2019","unstructured":"Daian e Silva DSO, Pinho TMG, Rachid MA, Barbosa-Stancioli EF, Da Fonseca FG (2019) The perennial use of the green fluorescent protein marker in a live Vaccinia virus Ankara recombinant platform shows no acute adverse effects in mice. Braz J Microbiol 50(2):347\u2013355. https:\/\/doi.org\/10.1007\/s42770-019-00067-5","journal-title":"Braz J Microbiol"},{"key":"247_CR22","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.provac.2011.10.009","volume":"5","author":"JA Roth","year":"2011","unstructured":"Roth JA (2011) Veterinary vaccines and their importance to animal health and public health. Procedia Vaccinol 5:127\u2013136. https:\/\/doi.org\/10.1016\/j.provac.2011.10.009","journal-title":"Procedia Vaccinol"},{"key":"247_CR23","doi-asserted-by":"publisher","unstructured":"Pulendran B, Li S, Nakaya HI (2010) Systems Vaccinology. Immunity 33:516\u2013529. https:\/\/doi.org\/10.1016\/j.immuni.2010.10.006","DOI":"10.1016\/j.immuni.2010.10.006"},{"key":"247_CR24","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.vetmic.2010.12.008","volume":"149","author":"P Martelli","year":"2011","unstructured":"Martelli P, Ferrari L, Morganti M, De Angelis E, Bonilauri P, Guazzetti S, Caleffi A, Borghetti P (2011) One dose of a porcine Circovirus 2 subunit vaccine induces humoral and cell-mediated immunity and protects against porcine circovirus-associated disease under field conditions. Vet Microbiol 149:339\u20133515. https:\/\/doi.org\/10.1016\/j.vetmic.2010.12.008","journal-title":"Vet Microbiol"},{"issue":"3-4","key":"247_CR25","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.vetmic.2008.10.007","volume":"135","author":"L Grau-Roma","year":"2009","unstructured":"Grau-Roma L, Hjulsager CK, Sibila M, Kristensen CS, L\u00f3pez-Soria S, En\u00f8e C, Casal J, B\u00f8tner A, Nofrar\u00edas M, Bille-Hansen V, Fraile L, Baekbo P, Segal\u00e9s J, Larsen LE (2009) Infection, excretion and seroconversion dynamics of porcine Circovirus type 2 (PCV2) in pigs from post-weaning multisystemic wasting syndrome (PMWS) affected farms in Spain and Denmark. Vet Microbiol 135(3-4):272\u2013282. 135:272\u2013282. https:\/\/doi.org\/10.1016\/j.vetmic.2008.10.007","journal-title":"Vet Microbiol"},{"key":"247_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.2460\/ajvr.2004.65.88","volume":"65","author":"M Sibila","year":"2004","unstructured":"Sibila M, Calsamiglia M, Segal\u00e9s J, Blanchard P, Badiella L, Le Dimna M, Jestin A, Domingo M (2004) Use of a polymerase chain reaction assay and an ELISA to monitor porcine Circovirus type 2 infection in pigs from farms with and without postweaning multisystemic wasting syndrome. Am J Vet Res 65:88\u201392. https:\/\/doi.org\/10.2460\/ajvr.2004.65.88","journal-title":"Am J Vet Res"},{"key":"247_CR27","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1136\/vr.146.26.762","volume":"146","author":"GM Rodr\u00edguez-Arrioja","year":"2000","unstructured":"Rodr\u00edguez-Arrioja GM, Segal\u00e9s J, Rosell C, Quintant J, Folch JM, Plana-Dur\u00e1n J, Mankertz A, Domingo M (2000) Serum antibodies to porcine Circovirus type 1 and type 2 in pigs with and without PMWS. Vet Rec 146:762\u2013764. https:\/\/doi.org\/10.1136\/vr.146.26.762","journal-title":"Vet Rec"},{"key":"247_CR28","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.vaccine.2004.01.032","volume":"22","author":"S Kamstrup","year":"2004","unstructured":"Kamstrup S, Barfoed AM, Frimann T, Ladekjaer-Mikkelsen AS, B\u00f8tner A (2004) Immunisation against PCV2 structural protein by DNA vaccination of mice. Vaccine 22:1358\u20131361. https:\/\/doi.org\/10.1016\/j.vaccine.2004.01.032","journal-title":"Vaccine"},{"key":"247_CR29","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1177\/104063870701900601","volume":"19","author":"T Opriessnig","year":"2007","unstructured":"Opriessnig T, Meng XJ, Halburg PG (2007) Porcine Circovirus type 2\u2013associated disease: update on current terminology, clinical manifestations, pathogenesis, diagnosis, and intervention strategies. J Vet Diagn Investig 19:591\u2013615. https:\/\/doi.org\/10.1177\/104063870701900601","journal-title":"J Vet Diagn Investig"},{"key":"247_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1746-6148-2-6","volume":"2","author":"P Meerts","year":"2006","unstructured":"Meerts P, Misinzo G, Lefebvre D, Nielsen J, B\u00f8tner A, Kristensen CS, Nauwynck HJ (2006) Correlation between the presence of neutralizing antibodies against porcine Circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease. BMC Vet Res 2:1\u201311. https:\/\/doi.org\/10.1186\/1746-6148-2-6","journal-title":"BMC Vet Res"},{"key":"247_CR31","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s12088-010-0026-9","volume":"50","author":"D Chandran","year":"2010","unstructured":"Chandran D, Reddy KB, Vijayan SP, Sugumar P, Rani GS, Kumar PS, Rajendra L, Srinivasan VA (2010) MVA recombinants expressing the fusion and hemagglutinin genes of PPRV protects goats against virulent challenge. Indian J Microbiol 50:266\u2013274. https:\/\/doi.org\/10.1007\/s12088-010-0026-9","journal-title":"Indian J Microbiol"},{"key":"247_CR32","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2217\/fvl.13.129","volume":"9","author":"BR Quinan","year":"2014","unstructured":"Quinan BR, Daian DSO, Coelho FM, Da Fonseca FG (2014) Modified Vaccinia virus Ankara as vaccine vectors in human and veterinary medicine. Futur Virol 9:173\u2013187. https:\/\/doi.org\/10.2217\/fvl.13.129","journal-title":"Futur Virol"},{"issue":"34(50)","key":"247_CR33","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1016\/j.vaccine.2016.10.058","volume":"7","author":"BR Quinan","year":"2016","unstructured":"Quinan BR, Versiani AF, da Fonseca FG (2016) A MVA construct expressing a secretable form of the dengue virus 3 envelope protein protects immunized mice from dengue-induced encephalitis. Vaccine 7(34(50)):6120\u20136122. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.058","journal-title":"Vaccine"},{"issue":"4","key":"247_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1002\/jgm.1300","volume":"11","author":"K Aravindaram","year":"2009","unstructured":"Aravindaram K, Kuo TY, Lan CW, Yu HH, Wang PH, Chen YS, Chen GH, Yang NS (2009) Protective immunity against porcine circovirus 2 in mice induced by a gene-based combination vaccination. J Gene Med 11(4):288\u2013301. https:\/\/doi.org\/10.1002\/jgm.1300","journal-title":"J Gene Med"},{"issue":"138","key":"247_CR35","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.prevetmed.2016.12.013","volume":"1","author":"LA White","year":"2017","unstructured":"White LA, Torremorell M, Craft ME (2017) Influenza A virus in swine breeding herds: combination of vaccination and biosecurity practices can reduce likelihood of endemic piglet reservoir. Prev Vet Med 1(138):55\u201369. https:\/\/doi.org\/10.1016\/j.prevetmed.2016.12.013","journal-title":"Prev Vet Med"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00247-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-020-00247-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00247-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T05:38:56Z","timestamp":1744177136000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-020-00247-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["247"],"URL":"https:\/\/doi.org\/10.1007\/s42770-020-00247-8","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"type":"print","value":"1517-8382"},{"type":"electronic","value":"1678-4405"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"14 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study is in accordance with the ethical principles of animal experimentation adopted by the Ethics Committee for Animal experiments (CEUA\/UFMG \u2013 protocol 273\/2008).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}